Effect of   9 - and   8 -tetrahydrocannabinol on the peripheral autonomic nervous system in vitro.
D000109:Acetylcholine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001341:Autonomic Nervous System / Q000187:drug effects*; D001464:Barium / Q000494:pharmacology; D002188:Cannabis / Q000494:pharmacology*; D003042:Cocaine / Q000494:pharmacology; D003964:Diaphragm / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D013759:Dronabinol / Q000008:administration & dosage / Q000494:pharmacology; D004347:Drug Interactions; D004357:Drug Synergism; D006168:Guinea Pigs; D006632:Histamine / Q000494:pharmacology; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D008297:Male; D009020:Morphine / Q000494:pharmacology; D009130:Muscle, Smooth / Q000187:drug effects; D009469:Neuromuscular Junction / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D010525:Peripheral Nerves / Q000187:drug effects*; D010791:Phrenic Nerve / Q000187:drug effects; D014649:Vas Deferens / Q000187:drug effects
D000804:Angiotensin II; D001464:Barium; D009020:Morphine; D001285:Atropine; D013759:Dronabinol; D006632:Histamine; D003042:Cocaine; D000109:Acetylcholine; D009638:Norepinephrine